Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunometabolism (United States) is Scopus-indexed (Q2, CiteScore 5.1), WoS ESCI. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2633-0407Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 100 / 250 | 60th | Q2 |
| Immunology and Allergy | 105 / 234 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 5.1.
Immunometabolism (United States) is Q2 in Endocrinology, Diabetes and Metabolism (rank 100 of 250) and Q2 in Immunology and Allergy (rank 105 of 234), by CiteScore 2025.
Immunometabolism (United States) is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.165, quartile Q2, with an H-index of 20.
Immunometabolism (United States) is published by Lippincott Williams and Wilkins. Its ISSN is 2633-0407.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunometabolism (United States) has an h-index of 27 and a 2-year mean of 3.51 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q2. On 2-year citations it ranks #66 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Immunometabolism (United States) published 22 papers in 2025; its busiest recent year was 2020 with 35. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from United States (83.5%), Germany (4%) and Ireland (1.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.